Trials / Completed
CompletedNCT07176585
A Prospective, Single-site, Single-group Value Study on the Diagnosis of Functional Myocardial Ischemia Based on IVUS Plaque Characteristics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 105 (actual)
- Sponsor
- Insight Lifetech Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the accuracy of IVUS-calculated percent atheroma volume (PAV) for diagnosing functional myocardial ischemia, using FFR as the gold standard.
Detailed description
This prospective, single-site, single-group target-value study aims to investigate the accuracy of intravascular ultrasound (IVUS)-based plaque characteristics in diagnosing functional myocardial ischemia, using coronary fractional flow reserve (FFR) as the gold standard.
Conditions
Timeline
- Start date
- 2025-09-23
- Primary completion
- 2026-01-04
- Completion
- 2026-01-04
- First posted
- 2025-09-16
- Last updated
- 2026-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07176585. Inclusion in this directory is not an endorsement.